Open AccessSodium restriction in patients with chronic heart failure and reduced ejection fraction: A randomized controlled trial
Author(s) -
Juan B. IveyMiranda,
Eduardo Almeida-Gutiérrez,
Raúl Herrera-Saucedo,
Edith Liliana Posada-Martínez,
Adolfo Chávez-Mendoza,
Genaro Hiram Mendoza-Zavala,
José Angel Cigarroa-López,
José Antonio Magaña-Serrano,
Roxana Rivera-Leaños,
Alberto de Jesús Treviño-Mejía,
Cristina Revilla-Matute,
Eduardo FloresUmanzor,
Nilda EspínolaZavaleta,
Arturo Orea-Tejeda,
J Garduño-Espinosa,
Guillermo Saturno-Chiu,
Veena S. Rao,
Jeffrey M. Testani,
Gabriela Borrayo–Sánchez
Publication year - 2023
Publication title -
cardiology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.573
H-Index - 33
eISSN - 1897-5593
pISSN - 1898-018X
DOI - 10.5603/cj.a2021.0098
Subject(s) - medicine , ejection fraction , heart failure , adverse effect , blood pressure , randomized controlled trial , natriuretic peptide , sodium , low sodium , confidence interval , low sodium diet , cardiology , renin–angiotensin system , chemistry , organic chemistry
Sodium restriction is recommended for patients with heart failure (HF) despite the lack of solid clinical evidence from randomized controlled trials. Whether or not sodium restrictions provide beneficial cardiac effects is not known.